INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 115 filers reported holding INTERSECT ENT INC in Q4 2015. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $299,000 | -51.5% | 10,674 | -52.8% | 0.00% | – |
| Q4 2021 | $617,000 | -10.6% | 22,607 | -10.9% | 0.00% | – |
| Q3 2021 | $690,000 | -1.6% | 25,380 | -38.1% | 0.00% | – |
| Q2 2021 | $701,000 | -47.9% | 41,024 | -36.4% | 0.00% | – |
| Q1 2021 | $1,346,000 | -41.5% | 64,506 | -35.8% | 0.00% | -100.0% |
| Q4 2020 | $2,300,000 | +44.3% | 100,445 | +2.8% | 0.00% | – |
| Q3 2020 | $1,594,000 | +3.2% | 97,755 | -14.3% | 0.00% | – |
| Q2 2020 | $1,544,000 | +83.4% | 114,062 | +60.7% | 0.00% | – |
| Q1 2020 | $842,000 | -38.4% | 70,958 | +29.3% | 0.00% | – |
| Q4 2019 | $1,366,000 | +49.1% | 54,870 | +1.9% | 0.00% | – |
| Q3 2019 | $916,000 | -57.1% | 53,835 | -42.6% | 0.00% | -100.0% |
| Q2 2019 | $2,135,000 | -39.7% | 93,787 | -14.9% | 0.00% | 0.0% |
| Q1 2019 | $3,543,000 | +2.5% | 110,230 | -10.2% | 0.00% | 0.0% |
| Q4 2018 | $3,458,000 | +11.2% | 122,712 | +13.5% | 0.00% | 0.0% |
| Q3 2018 | $3,109,000 | -24.7% | 108,149 | -1.8% | 0.00% | 0.0% |
| Q2 2018 | $4,127,000 | -10.5% | 110,175 | -6.0% | 0.00% | 0.0% |
| Q1 2018 | $4,609,000 | +68.3% | 117,250 | +38.8% | 0.00% | 0.0% |
| Q4 2017 | $2,738,000 | +70.7% | 84,483 | +64.1% | 0.00% | – |
| Q3 2017 | $1,604,000 | +17.6% | 51,476 | +5.5% | 0.00% | – |
| Q2 2017 | $1,364,000 | +9.3% | 48,810 | -32.9% | 0.00% | – |
| Q1 2017 | $1,248,000 | +5.9% | 72,777 | -25.3% | 0.00% | – |
| Q4 2016 | $1,179,000 | -28.4% | 97,477 | -6.2% | 0.00% | -100.0% |
| Q3 2016 | $1,646,000 | +32.0% | 103,909 | +7.8% | 0.00% | – |
| Q2 2016 | $1,247,000 | -97.3% | 96,393 | -96.0% | 0.00% | -100.0% |
| Q1 2016 | $46,106,000 | -10.5% | 2,426,603 | +6.0% | 0.02% | -10.0% |
| Q4 2015 | $51,495,000 | +30.9% | 2,288,725 | +36.2% | 0.02% | +25.0% |
| Q3 2015 | $39,334,000 | +47.2% | 1,680,937 | +80.1% | 0.02% | +60.0% |
| Q2 2015 | $26,719,000 | -35.4% | 933,275 | -41.7% | 0.01% | +25.0% |
| Q1 2015 | $41,384,000 | +290.5% | 1,602,136 | +180.4% | 0.01% | +100.0% |
| Q4 2014 | $10,599,000 | +79.1% | 571,378 | +49.7% | 0.00% | +100.0% |
| Q3 2014 | $5,918,000 | – | 381,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 238,698 | $3,781,000 | 3.74% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $4,356,000 | 1.32% |
| Broadfin Capital, LLC | 638,600 | $10,115,000 | 0.91% |
| Aisling Capital LLC | 248,498 | $3,936,000 | 0.81% |
| Bellevue Group AG | 205,325 | $3,252,000 | 0.59% |
| Iguana Healthcare Management, LLC | 180,000 | $2,852,000 | 0.51% |
| Rock Springs Capital Management LP | 345,000 | $5,465,000 | 0.34% |
| SECTORAL ASSET MANAGEMENT INC | 168,140 | $2,663,000 | 0.26% |
| FORMULA GROWTH LTD | 62,213 | $985,000 | 0.22% |
| MENTA CAPITAL LLC | 111,915 | $1,773,000 | 0.17% |